col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: IMA Press, LLC
  original article Journal Date Title Authors All Authors
1 [GO] Neurology neuropsychiatry Psychosomatics 2021―Sep―16 Acute inflammatory demyelinating pseudotumor after COVID-19 T. I. Yakushina, D. M. Yakushin, I. O. Shtang
2 [GO] Neurology neuropsychiatry Psychosomatics 2021―Sep―16 Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic E. V. Ivashkova, A. M. Petrov, M. V. Votintseva, I. D. Stolyarov
3 [GO] Modern Rheumatology Journal 2021―Aug―16 Septal panniculitis as manifestation of COVID-19: own data O. N. Egorova, R. G. Goloeva, D. I. Abdulganieva
4 [GO] Neurology neuropsychiatry Psychosomatics 2021―Jun―24 COVID-19 and epilepsy: Russian and international experience G. V. Odintsova
5 [GO] Neurology neuropsychiatry Psychosomatics 2021―Jun―24 Management tactics in patients with chronic cerebral ischemia during COVID-19 pandemic A. A. Kulesh
6 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19) V. A. Kutashov
7 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 COVID-19 vaccination guidelines for patients with multiple sclerosis N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, et al. (+4)
8 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions V. A. Golovacheva, G. R. Tabeeva, I. V. Kuznetsov
9 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 Anxiety and depression in COVID-19: treatment options V. E. Medvedev
10 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 Central pontine myelinolysis in the presence of SARS-CoV-2 infection (clinical observations) O. N. Voskresenskaya, A. A. Kovalenko, E. B. Nadbitova, V. V. Grinyuk, A. V. Klimanov, Yu. M. Shor
11 [GO] Modern Rheumatology Journal 2021―Apr―24 The Prospects of tumor necrosis factor α inhibitors use in patients with COVID-19 E. S. Aronova, B. S. Belov
12 [GO] Neurology neuropsychiatry Psychosomatics 2021―Feb―18 The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’ V. V. Kovalchuk
13 [GO] Neurology neuropsychiatry Psychosomatics 2021―Feb―18 Anxiety: phenomenology, epidemiology, and risk factors during the novel coronavirus SARS-CoV-2 (COVID-19) pandemic A. G. Merkin, S. S. Akinfieva, A. V. Martyushev-Poklad, O. P. Beloskurskaya, E. N. Dinov, S. L. Ostrovsky, et al. (+5)
14 [GO] Neurology neuropsychiatry Psychosomatics 2021―Feb―18 Depression during the COVID-19 pandemic (analysis of clinical cases) I. Yu. Dorozhenok
15 [GO] Neurology neuropsychiatry Psychosomatics 2021―Feb―18 Cognitive impairment in COVID-19 survivors T. M. Ostroumova, P. A. Chernousov, I. V. Kuznetsov
16 [GO] Neurology neuropsychiatry Psychosomatics 2020―Dec―13 COVID-19 and mental health: challenges and first conclusions V. E. Medvedev, O. A. Dogotar
17 [GO] Neurology neuropsychiatry Psychosomatics 2020―Dec―13 Somatization disorders of affective and neurotic registers during the COVID-19 pandemic (analysis of clinical cases) I. Yu. Dorozhenok
18 [GO] Neurology neuropsychiatry Psychosomatics 2020―Aug―05 Nervous system damage in COVID-19 with an emphasis on the management of patients with multiple sclerosis A. N. Boyko, S. A. Sivertseva, N. N. Spirin
19 [GO] Neurology neuropsychiatry Psychosomatics 2020―Jun―26 The first experience with Angiovit in the combination treatment of acute COVID-19 infection A. N. Boyko, N. A. Shamalov, O. V. Boyko, E. E. Arinina, O. V. Lyang, E. A. Dubchenko, et al. (+2)
20 [GO] Rheumatology Science and Practice 2020―Jun―24 DO NSAIDS CAUSE SPECIFIC COMPLICATIONS IN COVID-19 CORONAVIRUS INFECTION? A. E. Karateev, E. L. Nasonov, A. M. Lila
21 [GO] Rheumatology Science and Practice 2020―Jun―24 IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6 E. L. Nasonov
22 [GO] Modern Rheumatology Journal 2020―May―31 COVID-19: the new challenge for rheumatologists B. S. Belov, A. E. Karateev
23 [GO] Rheumatology Science and Practice 2020―Apr―27 CORONAVIRUS DISEASE 2019 (COVID-19): A RHEUMATOLOGIST’S THOUGHTS E. L. Nasonov


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.007 sec